Trial Profile
Ramosetron for the prevention of chemotherapy-induced nausea and vomiting
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 Sep 2014
Price :
$35
*
At a glance
- Drugs Ramosetron (Primary)
- Indications Chemotherapy-induced nausea and vomiting
- Focus Pharmacokinetics
- 29 Sep 2014 New trial record